We are committed to funding the most promising MND research, based on specific criteria and with clear relevance and potential for those living with MND.
All research we fund must be relevant to MND and, where possible, it should be clinically orientated, or in the translational areas between pre-clinical laboratory work and clinical trials with patients. We are also interested in research relating to health economics, burden of disease or patient relevant measurements.
These are the areas we focus on with our research funding:
Where the presence of an individual can start, or speed up, any of the research that meets our criteria.
Where existing drugs being used for other diseases could make a meaningful difference in MND.
Improving the understanding of MND, its causes and its progression, so as to help with the development of new treatments.
Research related to using gene therapy to change the cellular environment of MND.
Larger-scale clinical trials testing new treatments, which include meaningful numbers of patients, aimed at curing or making a meaningful impact on MND.
Where we have a specific area of research that we would like to commission related to a particular aspect of MND, geographical area, new discovery, or to improve our knowledge of the disease.